The transaction took place Aug. 10, at an average price of $1.56 a share.
With the acquisition, Mr. Flanagan now owns 1,431,814 shares of the company’s stock.
More articles on finance issues:
5 healthcare CFOs in the headlines
Ohio faces $558M loss in FY 2018 under proposed managed care organization tax change
CHS spin-off Quorum Health suffers heavy losses on impairment charges
Register to Attend Webinar
Presenters:
Christopher Kerns, Union Healthcare Insight|Eric Fontana, Union Healthcare Insight|Ben Gerber, WVU Medicine
Next Up in Financial Management
-
Five Democratic governors have asked HHS Secretary Robert F. Kennedy Jr. to delay the Jan. 1, 2027, compliance date for…
-
Chief transformation officers occupy one of healthcare’s most demanding and most consequential leadership roles. They not only envision a better…
-
Moody’s Ratings affirmed the “Aa3” rating and stable outlook for St. Louis-based Ascension, which operates 91 wholly owned or consolidated…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
